Medullary thyroid carcinoma: Management of lymph node metastases

Current Treatment Options in Oncology

Volumn 6, Issue 4, 2005, Pages 347-354

  Quayle, Frank Jay ^b   Moley, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; RADIOACTIVE IODINE; THYROXINE;

CALCITONIN BLOOD LEVEL; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MICRODISSECTION; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; REOPERATION; REVIEW; SURGICAL TECHNIQUE; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 24044472697     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-005-0038-6     Document Type: Review

References (19)

1. Hundahl SA, Fleming ID, Fremgen AM, et al.: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the United States, 1985-1995. Cancer 1998, 12:2638-2648.
2. Bergholm U, Bergstrom R, Ekbom A: Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 1997, 1:132-138.
3. Dralle H: Lymph node dissection and medullary thyroid carcinoma. BR J Surg 2002, 9:1073-1075.
4. Moley JF, Dilley WG, DeBenedetti MK: Improved results of cervical re-operation for medullary thyroid carcinoma. Ann Surg 1997, 6:734-740.
5. Tung WS, Vesely TM, Moley JF: Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 1995, 6:1024-1029.
6. Machens A, Gimm O, Ukkat J, et al.: Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 2000, 8:1909-1915.
7. Tisell LE, Dilley WG, Wells SA, Jr.: Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 1996, 1:34-39.
8. Zangeneh F, Gharib H, Goellner JR, et al.: Potential absence of prognostic implications of severe preoperative hypercalcitoninemia in medullary thyroid carcinoma. Endocr Pract 2003, 4:284-289.
9. Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 12:5658-5671.
10. Skinner MA: Management of hereditary thyroid cancer in children. Surg Oncol 2003, 2:101-104.
11. José G, Guillem MD: ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Surg Oncol 2005. In press.
12. Machens A, Niccoli-Sire P, Hoegel J, et al.: Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003, 16:1517-1525.
13. van Heerden JA, Grant CS, Gharib H, et al.: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990, 4:395-400.
14. Bergholm U, Adami HO, Bergstrom R, et al.: Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981. Cancer 1989, 6:1196-1204.
15. Shaha A: Thyroid cancer: surgical practice guidelines for major cancer sites. In Society of Surgical Oncology: Surgical Practice Guidelines. Edited by Byers R. Arlington Heights, IL: Society of Surgical Oncology; 1997.
16. Musholt TJ, Musholt PB, Dehdashti F, et al.: Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 1997, 6:1049-1060.
17. Tisell LE, Hansson G, Jansson S, et al.: Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986, 1:60-66.
18. Moley JF, Debenedetti MK, Dilley WG, et al.: Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Intern Med 1998, 6:521-526.
19. Moley JF, DeBenedetti MK: Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 1999, 6:880-887.